Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kjekshus

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Scandinavian Journal of Urology and Nephrology|July 1, 1984
Ace Inhibitors in Heart FailureJohn Kjekshus
European Heart Journal|April 18, 2015
Are statins failing in heart failure?John Kjekshus
European Journal of Heart Failure|July 27, 2007
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survivalJohn Kjekshus
Journal of the American College of Cardiology|January 5, 2008
Risk associated with statin treatmentJohn Kjekshus
Ebiomedicine|August 20, 2015
Inflammation: Friend and FoeJohn Kjekshus
Nature Clinical Practice. Cardiovascular Medicine|May 1, 2008
What are the effects of patient age and blood pressure on the cholesterol-related risk of vascular mortality?John Kjekshus
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: Statins should be used in patients with heart failureJohn Kjekshus
European Heart Journal|October 30, 2008
The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatmentJørgen Gravning, John Kjekshus
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 2003
[Use of beta-blockaders in heart failure]Lars Gullestad, John Kjekshus
Lancet (London, England)|September 21, 2002
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanKenneth Dickstein, John Kjekshus,
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Scandinavian Journal of Urology and Nephrology|July 1, 1984
Ace Inhibitors in Heart FailureJohn Kjekshus
European Heart Journal|April 18, 2015
Are statins failing in heart failure?John Kjekshus
European Journal of Heart Failure|July 27, 2007
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survivalJohn Kjekshus
Journal of the American College of Cardiology|January 5, 2008
Risk associated with statin treatmentJohn Kjekshus
Ebiomedicine|August 20, 2015
Inflammation: Friend and FoeJohn Kjekshus
Nature Clinical Practice. Cardiovascular Medicine|May 1, 2008
What are the effects of patient age and blood pressure on the cholesterol-related risk of vascular mortality?John Kjekshus
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: Statins should be used in patients with heart failureJohn Kjekshus
European Heart Journal|October 30, 2008
The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatmentJørgen Gravning, John Kjekshus
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 2003
[Use of beta-blockaders in heart failure]Lars Gullestad, John Kjekshus
Lancet (London, England)|September 21, 2002
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanKenneth Dickstein, John Kjekshus,
Pageof 12